1-6 of 6
Christina Bello
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Increased Bone Marrow Plasma Cells at Diagnosis Predicts Overall Mortality in AL Amyloidosis Patients Undergoing Risk-Adapted Stem Cell Transplant

Chrystal A. Landry, MD, Melody Smith, MD, Joanne F. Chou, Sean M. Devlin, PhD, Hani Hassoun, MD, Christina Bello, Ola Landgren, MD PhD, Sergio Giralt, MD, Raymond L. Comenzo, MD, Heather Landau, MD
Journal: Blood
Blood (2014) 124 (21): 2522.
https://doi.org/10.1182/blood.V124.21.2522.2522
Published: 2014
Journal Articles

Risk-Adapted Melphalan and Stem Cell Transplant for Systemic Light Chain Amyloidosis: A Single Institution Experience.

Heather Landau, MD, Daniel E Fein, Hani Hassoun, MD, Christina Bello, Joanne F Chou, Sean Devlin, PhD, Sergio Giralt, MD, Raymond L. Comenzo, MD
Journal: Blood
Blood (2012) 120 (21): 3109.
https://doi.org/10.1182/blood.V120.21.3109.3109
Published: 2012
Journal Articles

Long-Term Outcomes of Patients with Systemic Light Chain Amyloidosis (AL) Treated At Diagnosis with Risk-Adapted Stem Cell Transplant and Consolidation with Novel Agents.

Raymond L. Comenzo, MD, Daniel E Fein, Hani Hassoun, MD, Christina Bello, Joanne F Chou, Sean Devlin, PhD, Sergio A Giralt, MD, Heather Landau, MD
Journal: Blood
Blood (2012) 120 (21): 3150.
https://doi.org/10.1182/blood.V120.21.3150.3150
Published: 2012
Journal Articles

Urinary Excretion of Epinephrine and Dopamine Correlates with Efficiency of G-CSF Mobilized Stem Cells in Patients with AL Amyloidosis

Heather Landau, MD, Hani Hassoun, MD, James E. Hoffman, MD, Christina Bello, Elizabeth Hoover, Elyn Riedel, Paul S. Frenette, MD, FRCPC, Raymond L. Comenzo, MD
Journal: Blood
Blood (2011) 118 (21): 316.
https://doi.org/10.1182/blood.V118.21.316.316
Published: 2011
Journal Articles

Maintained Hematologic and Organ Responses at Two Years Following Stem Cell Transplant In Systemic Light-Chain Amyloidosis (AL) Using Short-Course Bortezomib and Dexamethasone Consolidation Therapy

Heather Landau, MD, Hani Hassoun, MD, Michael A. Rosenzweig, MD, Christina Bello, Elizabeth Hoover, Elyn Riedel, Alex Lesokhin, MD, Nikoletta Lendvai, MD, PhD, Adam Cohen, MD, Stephen Nimer, Raymond L. Comenzo, MD
Journal: Blood
Blood (2010) 116 (21): 2391.
https://doi.org/10.1182/blood.V116.21.2391.2391
Published: 2010
Journal Articles

Adjuvant Bortezomib and Dexamethasone Following Risk-Adapted Melphalan and Stem Cell Transplant in Systemic Light-Chain Amyloidosis (AL): A Phase II Study.

Heather Landau, MD, Hani Hassoun, MD, Adam D Cohen, MD, Alexander Lesokhin, MD, Christina Bello, Elizabeth Hoover, Elyn R Riedel, MD, Jennifer Ciminiello, RN, NP, Emily McCullagh, RN, NP-C, OCN, Stephen D Nimer, MD, Raymond Comenzo, MD
Journal: Blood
Blood (2009) 114 (22): 533.
https://doi.org/10.1182/blood.V114.22.533.533
Published: 2009